Coronavirus Update:What patients and families need to know
The Children's National Research Institute
- Childhood leukemia
- Hodgkin and Non-Hodgkin Lymphoma
- Adoptive cellular therapies
- Combination immunotherapies
- Fellowship Program, Pediatric Hematology/Oncology, Johns Hopkins/NCI, Baltimore/Bethesda, MD (2008-2012)
- Residency Program, Pediatrics, Johns Hopkins Hospital, Baltimore, MD (2006-2008)
- Internship Program, Pediatrics, Wayne State University, Detroit, MI (2005-2006)
- M.P.H., Epidemiology & Biostatistics, University of Massachusetts, Amherst, MA (2003-2005)
- M.B.B.S., Medicine, Lokmanya Tilak Municipal Medical Center, Mumbai, India (1997-2003)
Assistant Professor of Pediatrics, George Washington University School of Medicine and Health Sciences
Hema Dave, M.D., is an attending oncologist in the Division of Oncology at the Center for cancer and Blood Disorder at Children's National Hospital. She joined Children's National in 2012. She is a Physician Scientist in The Cell Enhancement and Technologies Institute (CETI) laboratory at the Center for Cancer Immunology Research at CNRI. She is an Assistant Professor on the tenure track at the George Washington School of Medicine.
She received her medical degree from the University of Mumbai, India, completed residency in Pediatrics from The Johns Hopkins Hospital and fellowship in Pediatric Hematology/Oncology from the combined program at The Johns Hopkins Hospital and the National Cancer Institute(Experimental Transplantation and Immunobiology Branch).
Dr. Dave's research interests are in T cell immunotherapies and hematologic malignancies. She is a translational investigator and currently conducting immunobiology correlative studies in patients with high risk Hodgkin Lymphoma enrolled on a large multi-institutional trial through the Children’s Oncology Group. She serves as a Principal Investigator and coinvestigator on many T cell therapy trials at Children's National. She also serves as the clinical director for the commercial chimeric antigen receptor T cell therapy program and is the institutional PI for industry sponsored CAR-T trial for Non-Hodgkin Lymphoma. She has received career development awards from the American Society of Hematology and the Lymphoma Research Foundation. Her goal is to advance novel immunotherapies to the clinic to improve the outcomes of children with leukemia/lymphoma.
She lives in Silver Spring, MD with her husband and daughter and enjoys hiking and camping in the National Parks and running.